Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: node 15581
New Real-World Evidence of Effective Treatment in Non-Small-Cell Lung Cancer with Capmatinib Share on: February 27, 2023 Non-small cell lung cancer (NSCLC) is an aggressive disease, with poor prognosis and a high likelihood of brain metastases. Overall …
Ashley Davis recognized for Best General Podium Research Presentation Award at ISPOR 2022 Share on: June 8, 2022 Image Congratulations to Ashley Davis, PhD, Director, Health Economics at RTI Health Solutions (RTI-HS), for being awarded Best General …
RTI-HS researcher to lead study that will seek perspectives of those affected by Alzheimer’s Share on: May 22, 2018 Understanding What Matters Most to Alzheimer's patients and their caregivers to help inform the drug development process. The Alzheimer’s …
Kenneth Rothman Receives Career Accomplishment Award from Society for Epidemiologic Research Share on: June 26, 2017 RTI Health Solutions is pleased to announce that Ken Rothman , DrPH, Distinguished Fellow and Vice President for Epidemiology Research , …
RTI International Acquires Medical Data Analytics Share on: April 6, 2020 Combination expands offering of real-world data/real-world evidence (RWD/RWE) to the world’s leading pharmaceutical and biotech companies RESEARCH TRIANGLE PARK, NC—RTI …
RTI Releases 2023 Corporate Responsibility and Sustainability Report Share on: February 7, 2024 Institute commits additional $9 million to internal sustainability investments to reduce GHG emissions RTI International, a nonprofit research institute, has …
Forbes Magazine Recognizes RTI International as One of the Best Employers for Diversity Share on: April 26, 2024 The 2024 America’s Best Employers for Diversity rankings resulted from surveying 170,000 US employees RESEARCH TRIANGLE PARK, N.C. — …
Forbes Best Employers for Diversity We are honored to be included in Forbes "Best Employers for Diversity" list. In determining the recipients of this award, Forbes survey participants were asked questions regarding topics like age, gender equality, …
PRO Analysis Portfolio Across Multiple Cancers OPPORTUNITY Our client had multiple phase 1, 2, and 3 clinical trials in hepatocellular carcinoma, renal cell carcinoma, and lymphoma. They needed an experienced partner to plan, analyze, and create reports …
Communicable Disease Models Utilize the power of communicable disease models to inform your analyses and help you better understand the potential impact of your novel healthcare intervention. You rely on realistic disease models to understand and …